Provided by Tiger Trade Technology Pte. Ltd.

Rapport Therapeutics, Inc.

27.84
-1.1600-4.00%
Post-market: 27.840.00000.00%18:42 EDT
Volume:291.60K
Turnover:8.13M
Market Cap:1.33B
PE:-9.72
High:28.95
Open:28.60
Low:27.23
Close:29.00
52wk High:42.27
52wk Low:7.73
Shares:47.66M
Float Shares:26.57M
Volume Ratio:0.89
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8633
EPS(LYR):-2.8633
ROE:-28.22%
ROA:-18.90%
PB:2.74
PE(LYR):-9.72

Loading ...

Company Profile

Company Name:
Rapport Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
2022
Employees:
84
Office Location:
99 High Street,Suite 2100,Boston,Massachusetts,United States
Zip Code:
02110
Fax:
- -
Introduction:
- -

Directors

Name
Position
Abraham N. Ceesay
Chief Executive Officer and Director
Steven M. Paul
Director and Chairman
David Bredt
Chief Scientific Officer and Director
James I. Healy
Director
Jeffrey K. Tong
Director
John Maraganore
Director
Raymond Kelleher
Director
Reid Huber
Director
Terry Ann Burrell
Director

Shareholders

Name
Position
Abraham N. Ceesay
Chief Executive Officer and Director
Cheryl Gault
Chief Operating Officer
Troy Ignelzi
Chief Financial Officer
Bradley S. Galer
Chief Medical Officer
David Bredt
Chief Scientific Officer and Director
Swamy Yeleswaram
Chief Development Officer